Medicinal Product Shortages - update - 26 June 2024

Notice type: Advisory

Date: 26/06/2024

This is the HPRA’s latest weekly update on medicines shortages. We publish this information each week to keep patients and healthcare professionals informed of current and resolved shortages.

We recognise that medicine shortages can be challenging for those who rely on medicines for their health and well-being. It is the case that for many medicines supplied in Ireland, there is more than one strength, form, pack size or brand available from different suppliers.

Your doctor or pharmacist will often be able to supply an alternative strength, form or product to ensure continuity of treatment if the medicine you have been taking is unavailable.

Resolved shortages

The following shortages have been resolved and supply has resumed to the Irish market:



Active Ingredient(s)

Hydrea 500 mg Hard Capsules


CHEPLAPHARM Arzneimittel GmbH


Olmesartan/Amlodipine Clonmel 40 mg/10 mg film-coated tablets


Clonmel Healthcare Ltd

Olmesartan medoxomil &

Amlodipine besilate

Valcyte 50 mg/ml powder for oral solution


CHEPLAPHARM Arzneimittel GmbH


Xolair 150 mg solution for injection in pre-filled syringe


Novartis Europharm Limited



Newly notified shortages
The HPRA has been notified of a shortage of the following products:


Active Ingredient(s)

Cefuroxime 750 mg powder for solution for injection/infusion


Fresenius Kabi Deutschland GmbH


Vancomycin 1000mg Powder for Concentrate for Solution for

Infusion and Oral Solution


Noridem Enterprises Limited


Please see the shortages section of the HPRA website for further information

The HPRA sends weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA

« Back